{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:19:44Z","timestamp":1787026784474,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Coxsackievirus (CV) A2 has emerged as an important etiological agent in the pathogen spectrum of hand, foot, and mouth disease (HFMD). The symptoms of CVA2 infections are generally mild, but worsen rapidly in some people, posing a serious threat to children\u2019s health. However, compared with enterovirus 71 detected frequently in fatal cases, limited attention has been paid to CVA2 infections because of its benign clinical course. In the present study, we identified three CVA2 strains from HFMD infections and used the cell-adapted CVA2 strain HN202009 to inoculate 5-day-old BALB\/c mice intramuscularly. These mice developed remarkably neurological symptoms such as ataxia, hind-limb paralysis, and death. Histopathological determination showed neuronophagia, pulmonary hemorrhage, myofiberlysis and viral myocarditis. Viral replication was detected in multiple organs and tissues, and CVA2 exhibited strong tropism to muscle tissue. The severity of illness was associated with abnormally high levels of inflammatory cytokines, including interleukin (IL)-6, IL-10, tumor necrosis factor \u03b1, and monocyte chemotactic protein 1, although the blockade of these proinflammatory cytokines had no obvious protection. We also tested whether an experimental formaldehyde-inactivated CVA2 vaccine could induce protective immune response in adult mice. The CVA2 antisera from the vaccinated mice were effective against CVA2 infection. Moreover, the inactivated CVA2 vaccine could successfully generate immune protection in neonatal mice. Our results indicated that the neonatal mouse model could be a useful tool to study CVA2 infection and to develop CVA2 vaccines.<\/jats:p>","DOI":"10.3389\/fmicb.2021.658093","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:16:17Z","timestamp":1622160977000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination"],"prefix":"10.3389","volume":"12","author":[{"given":"Wangquan","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-297","article-title":"Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009.","volume":"8","author":"Baek","year":"2011","journal-title":"Virol. J."},{"key":"B2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/jmv.1075","article-title":"Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis.","volume":"64","author":"Bendig","year":"2001","journal-title":"J. Med. Virol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/MOH.0000000000000389","article-title":"The regulation and importance of monocyte chemoattractant protein-1.","volume":"25","author":"Bianconi","year":"2018","journal-title":"Curr. Opin. Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13337-017-0366-8","article-title":"High prevalence of coxsackievirus A2 in children with herpangina in Thailand in 2015.","volume":"28","author":"Chansaenroj","year":"2017","journal-title":"Virusdisease"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1542\/peds.2006-3331","article-title":"Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005.","volume":"120","author":"Chen","year":"2007","journal-title":"Pediatrics"},{"key":"B7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1684-1182(10)60016-3","article-title":"Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children\u2019s hospital experience.","volume":"43","author":"Chen","year":"2010","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1016\/j.vaccine.2011.06.044","article-title":"Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.","volume":"29","author":"Dong","year":"2011","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1042\/CS20170009","article-title":"Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.","volume":"131","author":"Franca","year":"2017","journal-title":"Clin. Sci. (Lond)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/srep38874","article-title":"Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies.","volume":"6","author":"Fu","year":"2016","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.1073\/pnas.1217563110","article-title":"Transgenic mouse model for the study of enterovirus 71 neuropathogenesis.","volume":"110","author":"Fujii","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCRESAHA.119.315380","article-title":"Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals.","volume":"125","author":"Georgakis","year":"2019","journal-title":"Circ. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/JCM.00007-11","article-title":"Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A.","volume":"49","author":"Hu","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3201\/eid2403.171303","article-title":"Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015.","volume":"24","author":"Huang","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease.","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies.","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1128\/JVI.01779-10","article-title":"Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model.","volume":"85","author":"Khong","year":"2011","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.immunol.021908.132625","article-title":"Immunity to respiratory viruses.","volume":"27","author":"Kohlmeier","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"D708","DOI":"10.1093\/nar\/gkx932","article-title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV).","volume":"46","author":"Lefkowitz","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children.","volume":"370","author":"Li","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/srep31151","article-title":"A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71.","volume":"6","author":"Liou","year":"2016","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2014.02.015","article-title":"A murine model of coxsackievirus A16 infection for anti-viral evaluation.","volume":"105","author":"Liu","year":"2014","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.012","article-title":"Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants.","volume":"123","author":"Mao","year":"2010","journal-title":"Chin. Med. J. (Engl.)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation.","volume":"86","author":"Mao","year":"2012","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine.","volume":"10","author":"Mao","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","article-title":"Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains.","author":"Martin","year":"2003","journal-title":"J. Gen. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions.","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"B28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcv.2015.11.024","article-title":"Enterovirus infections in hospitals of Ile de France region over 2013.","volume":"74","author":"Molet","year":"2016","journal-title":"J. Clin. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1172\/JCI18125","article-title":"Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis.","volume":"112","author":"Morrison","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1099\/vir.0.79789-0","article-title":"Complete genome sequences of all members of the species Human enterovirus A.","author":"Oberste","year":"2004","journal-title":"J. Gen. Virol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2169\/internalmedicine.55.5292","article-title":"Fulminant Type 1 diabetes mellitus associated with coxsackie virus type A2 infection: a case report and literature review.","volume":"55","author":"Ohara","year":"2016","journal-title":"Intern. Med."},{"key":"B32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/JVI.00999-09","article-title":"Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease.","volume":"84","author":"Ong","year":"2010","journal-title":"J. Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S1474-4422(10)70209-X","article-title":"Clinical features, diagnosis, and management of enterovirus 71.","volume":"9","author":"Ooi","year":"2010","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-205","article-title":"Enteroviruses isolated from herpangina and hand-foot-and-mouth disease in Korean children.","volume":"9","author":"Park","year":"2012","journal-title":"Virol. J."},{"key":"B35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating 50 percent end-points.","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1128\/IAI.67.9.4531-4538.1999","article-title":"Reactivation of latent tuberculosis: variations on the Cornell murine model.","volume":"67","author":"Scanga","year":"1999","journal-title":"Infect. Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71.","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease.","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.MCHD-0022-2015","article-title":"Anti-TNF Therapy.","volume":"4","author":"Udalova","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL.","volume":"167","author":"Via","year":"2001","journal-title":"J. Immunol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2006.05.009","article-title":"Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis.","volume":"37","author":"Wang","year":"2006","journal-title":"J. Clin. Virol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-21-31","article-title":"Animal models of enterovirus 71 infection: applications and limitations.","volume":"21","author":"Wang","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008-12: an epidemiological study.","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.antiviral.2016.08.025","article-title":"A neonatal mouse model for the evaluation of antibodies and vaccines against coxsackievirus A6.","volume":"134","author":"Yang","year":"2016","journal-title":"Antiviral Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204359","article-title":"Persistent circulation of genotype D coxsackievirus A2 in mainland of China since 2008.","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1080\/22221751.2020.1823889","article-title":"Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys.","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1016\/j.vaccine.2019.07.046","article-title":"An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.","volume":"37","author":"Yao","year":"2019","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jmii.2016.08.012","article-title":"A case of recombinant coxsackievirus A2 infection with neurological complications in Taiwan.","volume":"50","author":"Yen","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3201\/eid1908.121498","article-title":"Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012.","volume":"19","author":"Yip","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00333-17","article-title":"Protective efficacies of formaldehyde-inactivated whole-virus vaccine and antivirals in a murine model of coxsackievirus A10 infection.","volume":"91","author":"Zhang","year":"","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1016\/j.vaccine.2018.09.069","article-title":"Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02450-16","article-title":"A neonatal murine model of coxsackievirus a6 infection for evaluation of antiviral and vaccine efficacy.","volume":"91","author":"Zhang","year":"","journal-title":"J. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.","volume":"370","author":"Zhu","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.658093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T14:20:40Z","timestamp":1725114040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.658093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,28]]},"references-count":54,"alternative-id":["10.3389\/fmicb.2021.658093"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.658093","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,28]]},"article-number":"658093"}}